NCT00228462View on ClinicalTrials.gov

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

PHASE3CompletedINTERVENTIONAL

Enrollment

197

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

April 30, 2006

Conditions

Schizophrenia

Interventions

DRUG

Seroquel (quetiapine)

Trial Locations (5)

Unknown

Investigative Site, Burgas

Investigative Site, Radnevo

Investigative Site, Sofia

Investigative Site, Bydgoszcz

Investigative Site, Tuszyn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY